| WUSS |
2026 |
Beyond a P-Value Vending Machine: Becoming a Research Partner, Not a Service Provider |
Mehrnaz Siavoshi |
source |
10 |
| WUSS |
2026 |
The Living Dead in Your Cohort: Immortal Time Bias Detection and Correction in SAS |
Mehrnaz Siavoshi |
source |
14 |
| PharmaSUG |
2026 |
Improving Risk-Based QA in Outsourced Studies Using Cross-Domain ADaM Derivation Comparisons |
Pallavi Sadhab |
source |
10 |
| PharmaSUG |
2026 |
Interactive Safety Data Visualization Platform: Transforming Adverse Event Analysis Review Through Dynamic Dashboards in Clinical Trials |
Nishanth Chinthala, Alexandr Hromcenco |
source |
5 |
| PharmaSUG |
2026 |
Path to Consistent Clinical Graphics: An R Shiny Gallery |
Michelle Harwood, Austin Taylor |
source |
12 |
| PHUSE US |
2026 |
Building the Information Infrastructure Required for AI with Human in the Loop [presentation] |
Tomás Sabat Stofsel |
source |
53 |
| PHUSE US |
2026 |
From Data Cutoffs to Decision-Making: Programming Futility Analysis in Oncology Clinical Trials |
Mani Mudumba |
source presentation source |
6 |
| PHUSE US |
2026 |
From SAS to R for TLGs: A Case Study on Implementing an 'R-First, SAS-QC' Workflow for Time-to-Event Analysis |
Adler Moisés Fallas Rodríguez |
source presentation source |
8 |
| PHUSE US |
2026 |
Practical Survival Analysis Techniques for Clinical Trials Using SAS |
Xue Ding, Tianchen Xu |
source presentation source |
10 |
| PHUSE US |
2026 |
Privacy-Preserving Methods for Oncology Research Using Differential Privacy |
Elena Valkanova |
source poster source |
12 |
| PHUSE US |
2026 |
Real-World Evidence Pavilion: Interactive Workshop: Bridging Estimands & Target Trial Emulation [presentation] |
Lauren Dang, Matt Baldwin |
source |
6 |
| PHUSE APAC |
2026 |
Beyond Log-Rank: Advanced Survival Analysis for Non-Proportional Hazards in Oncology Trials |
Jagdish Nikam |
source poster source |
7 |
| PHUSE APAC |
2026 |
Crafting a recipe for success : Aligning Target Product Profiles and study design to ensure statistical significance translates to clinical relevance and role of DGF |
Soumitra Kar, Novo Nordisk GBS |
source presentation source |
9 |
| PHUSE APAC |
2026 |
Innovative Strategies for Managing Missing Data in Real-World Data: Insights from APAC Global Capability Centers |
Likhita Kolli, Tuhin James Paul |
source poster source |
12 |
| PHUSE APAC |
2026 |
One-year Urate-Lowering Therapy Adherence and Risk of Major Osteoporotic Fracture: A Target Trial Emulation Study |
Seong Jun Byun |
source poster source |
5 |
| PHUSE EU |
2025 |
Inverse Probability Weighting in Multiple Groups: Balancing Baseline Characteristics and Improving Precision of Average Treatment Effect Estimation |
Dimitris Karletsos |
source presentation source |
11 |
| MWSUG |
2025 |
Conducting Survival Analysis in SAS using Medicare Claims as a Real-world data source |
Jayanth Iyengar |
source |
32 |
| WUSS |
2025 |
Conducting Survival Analysis in SAS using Medicare Claims as a Real-world data source |
Jayanth Iyengar |
source |
32 |
| PharmaSUG |
2025 |
Association of Alzheimer-s Disease with Cardiovascular Disease and Depression in Older Adults: Findings from the 2018 Nationwide Inpatient Sample |
Prayag Shah |
source |
27 |
| PharmaSUG |
2025 |
Conducting Survival Analysis in SAS using Medicare Claims as a Real-world data source |
Jayanth Iyengar |
source |
32 |
| PharmaSUG |
2025 |
How to compute common clinical trials statistics in R |
Oleksandr Babych |
source |
15 |
| PharmaSUG |
2025 |
Mastering the Maze of Oncology Endpoints: A Unified SAS Approach for Randomized Controlled Trial Analysis |
Yuxin Wang, Kelly Chao, Wenqing Yu, Hongbing Jin |
source |
11 |
| PharmaSUG |
2025 |
Time to Event Analysis from Sample Size Considerations to Results Interpretation in Simple Words |
Iryna Kotenko |
source |
8 |
| PHUSE US |
2025 |
Revolutionising Cancer Trials with Adaptive Designs and Bayesian Analysis |
Navneet Jha |
source presentation source |
11 |
| PHUSE US |
2025 |
SAS Programming approach for adjustment of treatment switching using Two-Stage Method |
Mani Mudumba |
source presentation source |
13 |
| PHUSE EU |
2024 |
Comparative Analysis: Creating Kaplan-Meier Plots Using SAS vs Python - A Step-by-Step Approach |
Mrityunjay Kumar, Ephicacy Lifescience |
source presentation source |
13 |
| PharmaSUG |
2024 |
Bayesian Methods in Survival Analysis: Enhancing Insights in Clinical Research |
Vadym Kalinichenko |
source |
11 |
| PharmaSUG |
2024 |
Kaplan-Meier Graph: a comparative study using SAS vs R |
Mrityunjay Kumar, Shashikant Kumar |
source |
11 |
| PHUSE EU |
2023 |
Comparison of power between different recurrent events analysis methods using simulation |
Soumitra Kar |
source presentation source |
7 |
| PharmaSUG |
2023 |
Generating Clinical Graphs in SAS and R - A Comparison of the Two Languages |
Kriss Harris, Endri Elnadav |
source |
48 |
| PharmaSUG |
2023 |
Guidelines for the Statistical Analysis in German Dossier Submissions |
Meiling Gao, Xi Qian, Hui Mao |
source |
8 |
| PharmaSUG |
2023 |
Meta-Analysis in R |
Lin Gu |
source |
8 |
| PHUSE US |
2022 |
Clinical Statistical Reporting in a Multilingual World [presentation] |
Michael S Rimler, Michael Stackhouse |
source |
11 |
| PHUSE US |
2022 |
Using the Nest-map-unnest Workflow in R for Sub-group Analysis in Clinical Trial Reporting [presentation] |
Mia Qi, Sheng-Wei Wang |
source video |
12 |
| PHUSE EU |
2021 |
An overview of regression approaches for the competing risks data |
Oksana Mykhailova, Julia Ditkovska |
source video presentation source |
6 |
| PHUSE EU |
2021 |
Comparison of PROC REPORT SAS and FLEXTABLE Package of R [presentation] |
Abu Zafar Mohammad Sami |
source video |
23 |
| PHUSE EU |
2021 |
Statistical Approaches in Complex Efficacy Analysis for Vaccine Trials [presentation] |
Drisya C A, Nijitha L M |
source video |
10 |
| PHUSE US |
2021 |
Software Demonstration: SD14: Accelerate your Transition to R in 4 months: Learn About the Accel2R Accelerated Learning Program [presentation] |
Steve Walker |
source |
22 |
| PHUSE US |
2021 |
Table-based Data Visualizations Using R [presentation] |
Matthew Kumar |
source video |
26 |
| PharmaSUG |
2021 |
Super Static SG Graphs |
Kriss Harris |
source |
7 |
| PharmaSUG |
2021 |
Survival Statistics with PROC LIFETEST and PROC PHREG: Pitfall-Avoiding Survival Lessons for Programmers |
Yun (Julie) Zhuo |
source |
10 |
| SGF |
2021 |
Super Static SG Graphs |
Kriss Harris |
source presentation |
7 |
| PHUSE EU |
2020 |
Super Static SG Graphics [presentation] |
Kriss Harris |
source video |
24 |
| SGF |
2020 |
Combination Weighted Log-rank Tests for Survival Analysis with Non-proportional Hazards |
Andrea Knezevic, Sujata Patil |
source |
10 |
| SGF |
2020 |
Testing Hypotheses for Equivalence and Non-inferiority with Binary and Survival Outcomes |
Joseph C. Gardiner |
source |
23 |
| PharmaSUG |
2020 |
%MVMODELS: a Macro for Survival and Logistic Analysis |
Jeffrey P. Meyers |
source |
23 |
| PharmaSUG |
2020 |
Demographic Table and Subgroup Summary Macro %TABLEN |
Jeffrey P. Meyers |
source |
12 |
| PharmaSUG |
2020 |
End-to-end Prostate-Specific Antigen (PSA) Analysis in Clinical Trials: From Mock-ups to ADPSA |
Joy Zeng, Varaprasad Ilapogu, Xinping Cindy Wu |
source |
12 |
| PharmaSUG |
2020 |
Sample size and HR confidence interval estimation through simulation of censored survival data controlling for censoring rate |
Giulia Tonini, Letizia Nidiaci, Simona Scartoni |
source |
10 |
| PHUSE US |
2020 |
Assessing Non-inferiority and Equivalence from Survival Data |
Chintan Arora, Parvee Kumar |
source presentation source |
7 |
| MWSUG |
2019 |
Survival Tips for Survival Analysis |
Xiaoting Wu |
|
13 |
| PharmaSUG |
2019 |
A SAS Macro to Provide Survival Functions along with Cox Regression Model Efficiently |
Chia-Ling (Ally) Wu |
source |
6 |
| PharmaSUG |
2019 |
Learning SAS GTL Basics with Practical Examples |
Jinit Mistry |
source |
12 |
| PharmaSUG |
2019 |
Progression-Free Survival (PFS) Analysis in Solid Tumor Clinical Studies |
Na Li |
source |
14 |
| PharmaSUG |
2019 |
Sample Size Determination with SAS Studio |
Bill Coar |
source |
13 |
| PharmaSUG |
2019 |
Useful SAS techniques in Efficacy Analysis for Oncology studies |
Joy Zeng |
source |
21 |
| SGF |
2019 |
Joint Analysis of Failure Times and Time-Varying Covariates |
Joseph C. Gardiner |
source |
22 |
| SGF |
2019 |
Sample Size Determination with SAS Studio |
William Coar |
source |
13 |
| PHUSE EU |
2018 |
Forest Plots in Survival Subgroup Analyses |
Michael Brockmann, Julia Benzing |
source presentation source |
11 |
| PHUSE EU |
2018 |
Methods for Survival Analysis with Competing Risks |
Laura Marquis, Leonie Wagner |
source presentation source |
8 |
| PHUSE EU |
2018 |
Sample Size: A Couple More Hints to Handle it Right Using SAS and R |
Andrii Artemchuk |
source presentation source |
11 |
| PHUSE EU |
2018 |
Subpopulation Treatment Effect Pattern Plot (STEPP) for Categorisation of Baseline Characteristics |
Andrea Parodi, Dimitri Petratchenko |
source poster source |
6 |
| MWSUG |
2018 |
Spotfire Clinical visualizations from SAS and R |
Zeqing Lu, Hillary Graham, Jessica Chen |
|
4 |
| PHUSE US |
2018 |
Interim Survival Analysis Across 3 Platforms |
Venita DePuy |
source presentation source |
22 |
| PharmaSUG |
2018 |
A SAS Macro to Generate Information Rich Kaplan-Meier Plots |
Chia-Ling (Ally) Wu |
source |
11 |
| PharmaSUG |
2018 |
Implementing the Rank-Preserving Structural Failure Time Model in SAS and R |
Bradford J. Danner, Indrani Sarkar |
source |
8 |
| PharmaSUG |
2018 |
Interactive Programming Using Task in SAS Studio |
Suwen Li |
source |
7 |
| PharmaSUG |
2018 |
Leveraging Standards for Effective Visualization of Early Efficacy in Clinical Trial Oncology Studies |
Kelci J. Miclaus, Lili Li |
source |
12 |
| PharmaSUG |
2018 |
Sense and Censorability: Learn censoring techniques with ADTTE for your survival |
Shilpakala Vasudevan |
source |
12 |
| SGF |
2018 |
Cause-Specific Analysis of Competing Risks Using the PHREG Procedure |
Changbin Guo |
source |
18 |
| SGF |
2018 |
Claim Risk Scoring Using Survival Analysis Framework and Machine Learning with Random Forest |
Yuriy Chechulin |
source |
15 |
| SGF |
2018 |
Getting Started with Survival Analysis |
Marc Huber |
source |
76 |
| SGF |
2018 |
The Cox Hazard Model for Claims Data |
Tanya Kolosova |
source |
16 |
| SCSUG |
2017 |
The Cox Hazard Model for Claims Data |
Samuel Berestizhevsky, Tanya Kolosova |
source |
17 |
| PHUSE EU |
2017 |
Surviving your Statistician: A Programmer's Guide to Survival Analysis |
James Diserens |
source presentation source |
11 |
| MWSUG |
2017 |
The Cox Hazard Model for Claims Data: Bayesian non-parametric approach |
Samuel Berestizhevsky, Tanya Kolosova |
|
17 |
| WUSS |
2017 |
The Cox Hazard Model for Claims Data |
Samuel Berestizhevsky, Tanya Kolosova |
source |
17 |
| PharmaSUG |
2017 |
Combining Survival Analysis Results after Multiple Imputation of Censored Event Times |
Jonathan L Moscovici, Bohdana Ratitch |
source |
11 |
| PharmaSUG |
2017 |
Survival 101 - Just Learning to Survive |
Leanne Goldstein, Rebecca Ottesen |
source |
20 |
| PharmaSUG |
2017 |
The %NEWSURV Family of Macros: An Update on the Survival Plotting Macro %NEWSURV and an Introduction to Expansion Macros |
Jeffrey P. Meyers |
source |
21 |
| SGF |
2017 |
A SAS Macro to Generate Kaplan-Meier Plot and Optional Estimates |
Chia-Ling (Ally) Wu |
source pdf |
11 |
| SESUG |
2016 |
Surviving the Interim: Insights Into Interim Survival Analyses |
Venita DePuy |
source |
31 |
| PHUSE EU |
2016 |
Clinical Graphs Using SAS |
Sanjay N. Matange |
source presentation source |
12 |
| PHUSE EU |
2016 |
Considerations in the Use of Propensity Scoresin Observational Studies |
Lawrence Rasouliyan, Estel Plana |
source presentation source |
17 |
| MWSUG |
2016 |
Use Multi-Stage Model to Target the Most Valuable Customers |
Chao Xu, Jing Ren, Hongying Yang |
|
10 |
| WUSS |
2016 |
Introduction to Survival Analysis in SAS |
Leanne Goldstein, Rebecca Ottesen |
source |
19 |
| PharmaSUG |
2016 |
Clinical Graphs Using SAS |
Sanjay N. Matange |
source |
19 |
| PharmaSUG |
2016 |
Cox proportional hazards regression to model the risk of outcomes per double increase in a continuous explanatory variable |
Seungyoung Hwang |
source |
4 |
| SGF |
2016 |
Clinical Graphs Using SAS |
Sanjay N. Matange |
source zip |
20 |
| SGF |
2016 |
Competing-Risks Analyses: An Overview of Regression Models |
Joseph C. Gardiner |
source |
22 |
| MWSUG |
2015 |
Cutpoint Determination Methods in Survival Analysis Using SAS: Updated %FINDCUT Macro |
Jeffrey P. Meyers, Jayawant N. Mandrekar |
|
7 |
| PHUSE EU |
2015 |
Adjusting Long-term Efficacy Estimates when Patients Cross Over to Experimental Treatment |
Sabine Lauer |
source presentation source |
11 |
| SESUG |
2015 |
Introducing Two-Way and Three-Way Interactions into the Cox Proportional Hazards Model Using SAS |
Seungyoung Hwang, Johns Hopkins |
source |
5 |
| PharmaSUG CN |
2015 |
A Macro to Automatically Select Covariates from Prognostic Factors and Exploratory Factors for Multivariate Cox PH Model |
Yu Cheng |
|
6 |
| PharmaSUG |
2015 |
Forest Plots: Old Growth versus GMO (Genetically Modified Organism) |
Scott Horton |
source |
12 |
| SGF |
2015 |
Analysis of Survey Data Using the SAS SURVEY Procedures: A Primer |
Patricia A. Berglund |
source |
19 |
| SGF |
2015 |
Cutpoint Determination Methods in Survival Analysis Using SAS: Updated %FINDCUT Macro |
Jayawant N. Mandrekar, Jeffrey P. Meyers |
source |
8 |
| SGF |
2015 |
Forest Plotting Analysis Macro %FORESTPLOT |
Jeffrey P. Meyers, Qian Shi |
source |
18 |
| SGF |
2015 |
Kaplan-Meier Survival Plotting Macro %NEWSURV |
Jeffrey P. Meyers |
source |
20 |
| SGF |
2015 |
Survival Analysis with Survey Data |
Joseph C. Gardiner |
source |
17 |
| SGF |
2015 |
Using the PHREG Procedure to Analyze Competing-Risks Data |
Ying C. So |
source |
9 |
| PHUSE EU |
2014 |
Evaluating the Tradeoff between Quality of Life through Quality-Adjusted Survival Analysis |
Lawrence Rasouliyan |
source presentation source |
12 |
| MWSUG |
2014 |
Kaplan-Meier Survival Plotting Macro %NEWSURV |
Jeffrey P. Meyers |
|
20 |
| PharmaSUG CN |
2014 |
Plotting Against Cancer: Creating Oncology Plots Using SAS |
Debpriya Sarkar |
|
30 |
| WUSS |
2014 |
A Statistical and Visual Exploration of the Surveillance, Epidemiology, and End Results (SEER) Database Using SAS |
Christopher Yim |
source |
10 |
| WUSS |
2014 |
Efficient Cut-point Estimation and Validation using PROC PHREG |
Alan Mitchell |
source |
7 |
| PharmaSUG |
2014 |
Kaplan-Meier Survival Plotting Macro %NEWSURV |
Jeffrey P. Meyers |
source |
19 |
| PharmaSUG |
2014 |
Survival 101 - Just Learning to Survive |
Leanne Goldstein, Rebecca Ottesen |
source |
19 |
| PharmaSUG |
2014 |
Survival Analysis Approaches and New Developments using SAS |
Jane Lu, David Shen |
source |
13 |
| PharmaSUG |
2014 |
Using SAS to Calculate and Compare Adjusted Relative Risks, Odds Ratios, and Hazard Ratios |
Besa Smith, Tyler C. Smith |
source |
23 |
| SGF |
2014 |
Plotting Against Cancer: Creating Oncology Plots Using SAS |
Debpriya Sarkar |
source |
30 |
| SGF |
2014 |
Regression Analysis of Duration and Severity Data: New Capabilities with SAS Software |
Joseph C. Gardiner |
source |
19 |
| SGF |
2014 |
Risk Factors and Outcome of Spinal Epidural Abscess from Incident Hemodialysis Patients from the United States Renal Data System between 2005 and 2008 |
Chan Jin, Jennifer White, Rhonda Colombo, Stephanie Baer, Usman Afza, M. Kheda, Lu Huber, Puja Chebrolu, N. Stanley Nahman, Kristina Kintziger |
source |
4 |
| WUSS |
2013 |
How to Compute Custom Hazard Ratio in SAS (V8.2&V9.2) PHREG Procedure |
Liguo Cheng, Yu Li |
source |
8 |
| WUSS |
2013 |
Survival 101 - Just Learning to Survive |
Leanne Goldstein, Rebecca Ottesen |
source |
24 |
| PHUSE EU |
2013 |
Computing the 'Competing Risks' - Modeling Survival Data with Competing Risk Events using SAS Macros |
Swapna Deshpande |
source presentation source |
10 |
| PHUSE EU |
2013 |
Extensions of Cox Model for Non-Proportional Hazards Purpose |
Jadwiga Borucka |
source presentation source |
10 |
| PHUSE EU |
2013 |
Lexis Expansion - Age-at-Risk Adjustment for Survival Analysis |
Lai San Hong, Sarah Lewington |
source |
5 |
| PharmaSUG |
2013 |
Bayesian Analysis of Survival Data with SAS PHREG Procedure |
Ryan Brady |
source |
8 |
| PharmaSUG |
2013 |
Time to Event Analysis in the Pharmaceutical and Medical Device Industries |
Helen M. Chmiel, Evan L. Ritzema |
source |
8 |
| SGF |
2013 |
Models for Ordinal Response Data |
Robin High |
source |
16 |
| NESUG |
2012 |
Building a Predictive Model for 30-Day Inpatient Readmission Using PROC PHREG |
Klaus Lemke |
|
13 |
| PharmaSUG |
2012 |
A SAS Macro for Biomarker Analysis using Maximally Selected Chi-Square Statistic With Application in Oncology |
Quan Jenny Zhou, Bala Dhungana |
source |
8 |
| SGF |
2012 |
Effect Modification, Confounding,Hazard Ratio, Distribution Analysis, and Probability of Non-normal Data for Head Neck Cancer |
Manojkumar B Agravat |
source |
40 |
| SGF |
2012 |
Using SAS to Extend Logistic Regression |
Dachao Liu |
source |
8 |
| MWSUG |
2011 |
Customizing Survival Plot by %Survivalplot Macro |
Zhong Yan |
|
12 |
| MWSUG |
2011 |
Increased Life Expectancy from Positive Perceptions of Retirement |
Reuben Ng, Deepak C. Lakra, Becca R. Levy |
|
10 |
| MWSUG |
2011 |
Using SAS to Extend Logistic Regression |
Dachao Liu |
|
8 |
| SGF |
2011 |
An Introduction to Survival Analysis Using Complex Sample Survey Data |
Patricia A. Berglund |
source |
20 |
| SGF |
2011 |
Matching-Adjusted Indirect Comparison Analysis Using Common SAS 9.2 Procedures |
Elisabetta Malangone, Steven Sherman |
source |
6 |
| SCSUG |
2010 |
Impact of model mis-specification on conditional power in interim survival analysis |
Chao L. Chen |
source |
9 |
| PHUSE EU |
2010 |
Assesment of Cox Proportional Hazard Model Adequacy Using PROC PHREG and PROC GPLOT |
Jadwiga Borucka |
source presentation source |
13 |
| PHUSE EU |
2010 |
Forest Plots and SAS |
Anne Barfield |
source |
5 |
| MWSUG |
2010 |
Using SAS to Assess and Model Time-to-Event Data with Non-Proportional Hazards |
Michael G. Wilson |
|
24 |
| PharmaSUG |
2010 |
An Overview of the CLASS, CONTRAST, and HAZARDRATIO Statements in the SAS 9.2 PHREG Procedure |
Paul T. Savarese, Michael J. Patetta |
|
23 |
| PharmaSUG |
2010 |
Tips for Creating Oncologic Efficacy Summary Tables using PROC LIFETEST and PROC PHREG |
Scott Michael Ward |
|
7 |
| SGF |
2010 |
An Overview of the CLASS, CONTRAST, and HAZARDRATIO Statements in the SAS 9.2 PHREG Procedure |
Paul T. Savarese, Michael J. Patetta |
source |
23 |
| SGF |
2010 |
Creating Forest Plots from Pre-computed Data Using PROC SGPLOT and Graph Template Language |
Zoran Bursac |
source |
9 |
| SGF |
2010 |
Survival Analysis: Overview of Parametric, Nonparametric, and Semiparametric Approaches and New Developments |
Joseph C. Gardiner |
source |
23 |
| SESUG |
2009 |
Developing Business Failure Prediction Models Using SAS Software |
Oki Kim |
source |
10 |
| WUSS |
2009 |
Computing Hazard Ratios and Confidence Intervals for a Two-Factor Cox Model with Interaction Terms |
Marla J. Husnik, Jing Wang |
source |
10 |
| WUSS |
2009 |
Developing Business Failure Prediction Models Using SAS Software |
Oki Kim |
source |
10 |
| PharmaSUG |
2009 |
Computing Hazard Ratios and Confidence Intervals for a Two-Factor Cox Model with Interaction Terms |
Jing Wang, Fred Hutchinson Cancer |
|
10 |
| SGF |
2009 |
Easier Exploratory Analysis for Epidemiology: A Grad Student "How-To" Paper |
Elisa L. Priest, Brian Adams, Lori A. Fischbach |
source |
11 |
| SGF |
2009 |
Test Linearity between Continuous Confounder and Binary Outcome First, Run Multivariate Regression Analysis Second |
Jiming Fang, Peter C. Austin, Jack V. Tu |
source |
8 |
| WUSS |
2008 |
Evaluation of a Hospice Care Referral Program Using Cox Proportional Hazards Model |
Lida Gharibvand, Daniel R. Jeske, Solomon Liao |
source |
16 |
| SESUG |
2008 |
Surviving Survival Analysis - An Applied Introduction |
Christianna S. Williams |
source |
17 |
| PHUSE EU |
2008 |
A gentle introduction to Survival Analysis |
Martin Scottt, Angelo Tinazzi |
source |
13 |
| MWSUG |
2008 |
Survival Methods for Correlated Time-to-Event Data |
James Bena, Shannon McIntyre |
|
3 |
| NESUG |
2008 |
Surviving Survival Analysis - An Applied Introduction |
Christianna S. Williams |
|
17 |
| PharmaSUG |
2008 |
Sample Size Estimation for Trials of Recurrent Events |
Kuolung Hu |
|
8 |
| WUSS |
2007 |
Health Outcomes Research Using Time-to-Event Analytic Approaches |
Tyler C. Smith, Besa Smith |
source |
22 |
| WUSS |
2007 |
They Were Our Dreams - Tables and Graphics for Survival Analysis using ODS |
Wei Cheng |
source |
13 |
| PNWSUG |
2007 |
Utilizing PHREG for Cox proportional hazards regression modeling with time-varying covariates |
Marla J. Husnik, Eugene Huang |
|
14 |
| PharmaSUG |
2007 |
Graphing Estimates of Regression Models for Discrete and Limited Dependent Variables |
Jianming He, David Budd |
|
10 |
| MWSUG |
2006 |
Checking Assumptions in the Cox Proportional Hazards Regression Model |
Brenda W Gillespie |
|
70 |
| PHUSE EU |
2006 |
The Hazards of Modelling Proportional Hazards in SAS |
Erika Daly, Farzana Sufi |
source |
4 |
| WUSS |
2006 |
Get the Correct Hazard Ratio from SAS PROC PHREG Procedure |
Betty Ying Wang |
source |
7 |
| PharmaSUG |
2006 |
Sample Size Calculation and Timeline Estimate for Progression-Free Survival |
Chung-Kuei Chang |
|
10 |
| SUGI |
2006 |
A System of SAS Macros for Producing Statistical Reports |
Greg A. Grandits |
source |
7 |
| WUSS |
2005 |
Graphing the Probability of Event as a Function of Time Using Survivor Function Estimates and the SAS System's PROC PHREG |
Tyler C. Smith, Besa Smith |
source |
18 |
| WUSS |
2004 |
Kaplan Meier And Cox Proportional Hazards Modeling: Hands On Survival Analysis |
Tyler C. Smith, Besa Smith |
source |
14 |
| MWSUG |
2004 |
A System of SAS Macros for Producing Statistical Reports |
Greg A. Grandits, Ken Svendsen |
|
8 |
| MWSUG |
2004 |
SAS Macros to Implement Survival Analyses for Oncology Clinical Trials |
Adeline Yeo |
|
5 |
| SUGI |
2004 |
An Introduction to Matching and Its Application Using the SAS System |
Jayawant N. Mandrekar, Sumithra J. Mandrekar |
source |
9 |
| PharmaSUG |
2002 |
Recovering Lost Lines: Using the Whole Page with Proc Report |
Richard R. Allen |
|
6 |
| WUSS |
2001 |
A Survival Analysis from the Ground Up, Using Cox Proportional Hazards Modeling |
Tyler C. Smith, Besa Smith, Margaret A. K. Ryan |
source |
8 |
| SUGI |
2001 |
Survival Analysis and the Application of Cox's Proportional Hazards Modeling Using SAS |
Tyler C. Smith, Besa Smith |
source |
9 |
| SESUG |
2000 |
Can A New Interpretation Of Survival Data Help Patients Successfully Modify Adverse Risk Profiles? |
Gregory L. Pearce |
source |
5 |
| WUSS |
2000 |
Graphing the Probability of Hospitalization as a Function of Time Using Estimates and the SAS System's PROC PHREG |
Tyler C. Smith |
source |
7 |
| NESUG |
1998 |
A Simulation Study of Estimators In Stratified Proportional Hazard Models |
Hsi-Wen Liao |
|
8 |
| SEUGI |
1998 |
SCHARP: Survival Curve and Hazard Ratio Program |
Angelo Tinazzi, Jayne Tierney, Lesley Stewart, Max Parmar, Valter Torri |
source |
9 |
| NESUG |
1997 |
Creating Complex Graphics for Survival Analyses with the SAS System |
Steven E. Elkin |
|
7 |
| SUGI |
1997 |
Creating Complex Graphics for Survival Analyses with the SAS System |
Steven E. Elkin, William Mietlowski, Kevin McCague, Andrea Kay |
source |
6 |
| MWSUG |
1995 |
A Macro System for Calling PROC GPLOT For General Usage But Also Having a Major Application for PROCS LIFETEST and PHREG Plots |
Hugh Geary |
|
6 |
| SUGI |
1989 |
The PHGLM Procedure for Time-Dependent Covariates - and the Case-Cohort Design |
David Yu-Wu Pee, Sholom Wacholder |
source |
6 |
| SUGI |
1986 |
Verifying Assumptions of the Cox Proportional Hazards Model |
Frank E. Harrell Jr., Kerry L. Lee |
source |
6 |